VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the long-term safety of VAXZEVRIA

Trial Identifier:	D8111C00005
Sponsor:	AstraZeneca
NCTID::	NCT05135455
Start Date:	April 2022
Primary Completion Date:	May 2023
Study Completion Date:	May 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Japan	Akita, Japan
Japan	Chiba, Japan
Japan	Hyogo, Japan
Japan	Kumamoto, Japan
Japan	Mie, Japan
Japan	Shizuoka, Japan
Japan	Tokyo, Japan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.